Company record
SpecGx, LLC
0 FDA warning letters since 2023 and 2 recalls in the last 12 months.
Get an email the day FDA posts anything new about SpecGx, LLC.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Jan 14 | Class II | SpecGx, LLC Drug |
Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0523-01. Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets. FDA notice D-0254-2026 |
| Jan 14 | Class II | SpecGx, LLC Drug |
Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0522-01. Case label: SpecGx LLC, NDC 0406052201, Exp. 2027/03, Lot: 0522J23493 Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets. FDA notice D-0255-2026 |